Additional Paid-In Capital (Narrative) (Details)					1 Months Ended	3 Months Ended		6 Months Ended
	May 14, 2021 USD ($) $ / shares	May 14, 2021 USD ($) shares	May 11, 2021	Jan. 11, 2021 USD ($) $ / shares shares	May 19, 2021 USD ($) shares	Jun. 30, 2021 USD ($)	Jun. 30, 2020 USD ($)	Jun. 30, 2021 USD ($) shares	Jun. 30, 2020 USD ($)
Schedule of Additional Paid In Capital [Line Items]
Stock based compensation						$ 25,000	$ 53,000	$ 56,000	$ 124,000
atai Life Sciences [Member]
Schedule of Additional Paid In Capital [Line Items]
Amount of company owned by significant investor			25.00%
Investment made by significant investor	$ 12,346,300	$ 12,346,300
Number of common stock shares issued to atai Life Sciences | shares		37,300,000
Number of warrants issued to atai Life Sciences | shares		22,380,000
Gross proceed from sale of common stock and warrants		$ 12,346,300
Exercise price of warrants | $ / shares	$ 0.35
Right to subscribe number of additional units | shares								130,000,000
Description of additional units								Each additional unit will be comprised of (i) one share of common stock and (ii) one half of one warrant.
Description of additional unit price								The price for the additional units will be (i) until the date which is 12 months following the closing, $0.331 (subject to certain exceptions), and (ii) following the date which is 12 months following the closing, the lower of (A) a 20% premium to the market price on the date of purchase, and (B) $0.50 if purchased in the second year following closing and $0.75 if purchased in third year following closing. Each additional warrant will entitle atai, for a period of three years from the date of issuance, to purchase one share at the lesser of either (i) a 20% premium to the price of the corresponding additional share
Maximum number of warrants exercisable | shares								44,000,000
Employee [Member]
Schedule of Additional Paid In Capital [Line Items]
Stock based compensation								$ 56,000	100,000
2016 Stock Option Plan [Member] | Stock options [Member]
Schedule of Additional Paid In Capital [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares				150,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares				$ 0.27
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term				2 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage				25.00%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period				10 years
Stock Granted, Value, Share-based Compensation, Gross				$ 25,000
Stock options granted to consultant [Member]
Schedule of Additional Paid In Capital [Line Items]
Stock based compensation								0	24,000
Unrecognized stock-based compensation [Member]
Schedule of Additional Paid In Capital [Line Items]
Stock based compensation								$ 141,000	$ 33,000
Deferred Share Units [Member]
Schedule of Additional Paid In Capital [Line Items]
Deferred share units grants in period | shares					390,625
General and administrative expenses					$ 207,000